(GLJ) Grenke - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000A161N30

GLJ: Leasing, Banking, Factoring

Grenke AG, a financial services provider with a strong focus on small and medium-sized enterprises (SMEs), operates across multiple jurisdictions, including Germany, France, Italy, and other international markets. The company’s business is segmented into three core areas: Leasing, Banking, and Factoring. Its leasing division is particularly extensive, offering a wide array of services such as financing for commercial lessees, rental agreements, maintenance, and protection plans, as well as the sale of used equipment. Grenke also specializes in small-ticket leasing for IT products, including PCs, notebooks, servers, and software, along with office communication devices like telephones and copiers. Additionally, the company leases medical technology products, small machinery, security systems, and equipment for the green economy, such as wallboxes, photovoltaic systems, and electric bicycles.

In its banking segment, Grenke provides fixed deposits for both private and business customers through its digital platform. It also offers tailored financing solutions for business start-ups, development loans for SMEs, and self-employed professionals. The factoring division focuses on small-ticket factoring services, enabling businesses to manage their cash flow more effectively. Originally established in 1978 as GrenkeLeasing AG, the company rebranded to Grenke AG in May 2016 to reflect its expanded service portfolio. Headquartered in Baden-Baden, Germany, Grenke AG has built a reputation for delivering flexible financial solutions to SMEs, a segment often underserved by larger financial institutions.

From a financial perspective, Grenke AG’s market capitalization stands at approximately 759.56 million euros, reflecting its mid-sized position in the consumer finance sector. The company’s price-to-earnings (P/E) ratio of 9.03 suggests a valuation that is relatively conservative compared to industry peers, while the forward P/E of 12.72 indicates expectations of future earnings growth. The price-to-book (P/B) ratio of 0

Additional Sources for GLJ Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

GLJ Stock Overview

Market Cap in USD 824m
Sector Financial Services
Industry Credit Services
GiC Sub-Industry Consumer Finance
IPO / Inception

GLJ Stock Ratings

Growth 5y -78.4%
Fundamental 18.1%
Dividend 17.2%
Rel. Strength Industry -48.4
Analysts -
Fair Price Momentum 14.78 EUR
Fair Price DCF 196.07 EUR

GLJ Dividends

Dividend Yield 12m 2.43%
Yield on Cost 5y 0.90%
Annual Growth 5y -22.49%
Payout Consistency 95.2%

GLJ Growth Ratios

Growth Correlation 3m 68.9%
Growth Correlation 12m -55.1%
Growth Correlation 5y -81.5%
CAGR 5y -22.92%
CAGR/Max DD 5y -0.28
Sharpe Ratio 12m -0.09
Alpha -46.91
Beta 1.05
Volatility 43.39%
Current Volume 1583.7k
Average Volume 20d 87.6k
What is the price of GLJ stocks?
As of March 14, 2025, the stock is trading at EUR 13.90 with a total of 1,583,715 shares traded.
Over the past week, the price has changed by -24.70%, over one month by -14.72%, over three months by -11.58% and over the past year by -39.66%.
Is Grenke a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Grenke is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 18.09 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GLJ as of March 2025 is 14.78. This means that GLJ is currently overvalued and has a potential downside of 6.33%.
Is GLJ a buy, sell or hold?
Grenke has no consensus analysts rating.
What are the forecast for GLJ stock price target?
According to ValueRays Forecast Model, GLJ Grenke will be worth about 16 in March 2026. The stock is currently trading at 13.90. This means that the stock has a potential upside of +14.82%.
Issuer Forecast Upside
Wallstreet Target Price 28.2 102.9%
Analysts Target Price - -
ValueRay Target Price 16 14.8%